Chicago (ots/PRNewswire) - -- BYETTA offers added benefits of progressive weight loss in an analysis of the longest extension study to date -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced three-year, open-label study results that showed treatment with ...
Chicago (ots/PRNewswire) - - Study also showed added benefits of reductions in cardiovascular risk factors and progressive weight loss - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced results from a study that showed BYETTA(R) (exenatide) injection in ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Company Information 21.06.2007 Boudry, 21 June 2007 - The Neuchâtel-based industrial group Cicor Technologies, which specializes in complex printed circuit boards, in the complementary area of contract electronic manufacturing services and in ...
San Jose, California (ots/PRNewswire) - - 64- and 48-pin Flash Microcontrollers with USB OTG Atmel(R) Corporation (Nasdaq: ATML) introduced today a second family based on the AVR(R)32 UC core, its 32-bit Flash microcontroller with DSP extensions. Developed for low power PC-centric applications, the AVR32 UC3B Series of MCUs has Full-Speed (12 Mbps) USB 2.0 with On-The-Go (OTG) capability. On-chip SRAM ranges ...
Oss, The Netherlands (ots/PRNewswire) - Sugammadex - the novel selective relaxant binding agent (SRBA) being developed by Organon, the human healthcare business unit of Akzo Nobel - demonstrated in a Phase III pivotal trial a 9-12 times faster reversal of neuromuscular blockade as compared to neostigmine, without ...
Chicago (ots/PRNewswire) - - Study Highlights Quality-of-Life Data ALIMTA(R) (pemetrexed for injection) showed additional utility in the treatment of the most diagnosed type of cancer(i), according to data presented today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO). ...
Chicago (ots/PRNewswire) - - Five Phase III Early-Stage Breast Cancer Studies Underway With GEMZAR GEMZAR(R) (gemcitabine HC1 for injection), approved in combination with paclitaxel (Taxol(R)) in the first-line, post-surgical treatment of metastatic breast cancer, was the subject of a study ...
Indianapolis (ots/PRNewswire) - - 37 Thoracic Cancer Studies; 11 Breast Cancer Studies; 9 Targeted Agent Studies Lilly Oncology will unveil 76 studies at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from June 1-5, 2007. The company will present important data on GEMZAR(R) (gemcitabine HCl for injection), ...
Vienna, Austria (ots/PRNewswire) - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced new data that showed that, in moderate to severe plaque psoriasis patients, ENBREL(R) (etanercept) reduced the severity of nail psoriasis by more than 28 percent at 12 weeks and reduced the signs and ...
Collegeville, Pennsylvania and Tarrytown, New York (ots/PRNewswire) - - Application for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that Wyeth has ...
Vancouver, Canada (ots/PRNewswire) - Tinka Resources Limited (TSXv - TK; Frankfurt - TLD (WKN A0B 884); Pinksheets - TKRFF) VANCOUVER, Canada, April 25 /PRNewswire/ -- Mr. Andrew Carter, President, is pleased to announce that the Company has retained ESONDI S.A. Peru as the drill contractor to undertake the initial drill program at the Company's 7,000 ...
Tip announcement for financial statements transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The financial statement is available: in the internet at: http://www.villeroy-boch.com/index.php?id=1382&L=1 in the internet on: 26.04.2007 additional statements: ...
The Financial Markets Association World Congress
Montreal, Canada (ots/PRNewswire) - Leading international financial market professionals from over 65 countries will converge in Montreal, Canada, to share insight on financial markets trends and learn about the latest in technology and information services. The congress offers business development opportunities, ...
Trappes, France (ots/PRNewswire) - Production began this week at Nissan's factory, situated in Sunderland, north-east England, of the new Qashqai compact crossover equipped with the state-of-the-art 2.0-litre dCi engine. Equipped with this engine, the Qashqai is available in both 2WD and 4WD drivetrains. The 2.0-litre dCi engine - engine code M1D - produces 110kW (150HP) at 4000rpm and 320Nm of torque at 2000rpm, ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Company Information 27.03.2007 Correction: Accidentally publication under § 30 e WpHG Haarlem / Netherlands. Dr. Fred Wilsdorf (50) will be the new Chief Financial Officer of LYCOS Europe ...
London (ots/PRNewswire) - - METEOR Trial Shows CRESTOR Slowed Progression of Atherosclerosis in People at Low-Risk of Coronary Heart Disease (Framingham 10 Year Risk ...
Other capital market information transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 22.03.2007 Dr. Fred Wilsdorf appointed new Chief Financial Officer of LYCOS Europe N.V. Haarlem / Netherlands. Dr. Fred Wilsdorf (50) will be the new Chief Financial Officer of LYCOS ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 22.03.2007 D i e t l i k o n, 22 March 2007. Born from the merger of the two most important Swiss construction enterprises, Zschokke and Batigroup, the Implenia Group, reports a successful ...
Bristol -Myers Squibb Company and Otsuka Pharmaceutical Co. Ltd
Madrid (ots/PRNewswire) - - New Survey Indicates There is Room for Improvement in Physical Health Management Strategies for People Living With Schizophrenia New data presented at the 15th European Congress of Psychiatry (AEP) indicates that the impact of weight gain and metabolic abnormalities associated ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Company Information/share split 26.02.2007 PALFINGER Proposes Share Split Bergheim / Salzburg, February 26th, 2007 PALFINGER, the world market leader for truck-mounted knuckle-boom cranes, is proposing a 1:4 stock split for approval at its ...
Vancouver, Canada (ots/PRNewswire) - StrataGold Corporation (TSX: SGV) is pleased to provide a review of our 2006 exploration and development programs at Tassawini and Barama JV, Guyana and Dublin Gulch, Yukon. Since our corporate update at the end of August (see August 30, 2006 news release), the Company has announced several new discoveries at Dublin Gulch, ...
Alderley Park, England (ots/PRNewswire) - - For Non-US Healthcare Press Only AstraZeneca today announced RECENTIN(TM) as the global trademark for AZD2171, its oral, highly potent and selective vascular endothelial growth factor (VEGF) signalling inhibitor. AZD2171 is currently in Phase II/III development for advanced non-small cell lung cancer (NSCLC) and ...
Cape Town, South Africa (ots/PRNewswire) - - First Rimonabant Trial with HbA1c as a Primary Endpoint Sanofi-aventis announced today that new data on rimonabant, its first-in-class cannabinoid type 1 (CB1) receptor blocker, showed that patients with type 2 diabetes not currently treated with anti-diabetic ...
Vancouver, Canada, November 29 (ots/PRNewswire) - StrataGold Corporation (SGV-TSX) is pleased to announce the commencement of a 2000 metre (m) diamond drilling (DD) program at Monosse, Guyana. Monosse is subject to a joint venture agreement (the "Agreement" or 'Barama JV') (see press release dated October 3, 2005) with Newmont Overseas Exploration Limited, a subsidiary of U.S.-based Newmont Mining Corporation (NYSE ...
Shire Pharmaceuticals Group Plc
Basingstoke, England and San Diego, California, November 20 (ots/PRNewswire) - - Further Data Support the Contribution of FOSRENOL(R) (Lanthanum Carbonate) to the Overall Renal Health of the ESRD Patient While Reducing Mean Phosphate Levels to Within Guideline Targets New data presented on Friday 17th ...
Glasgow, Scotland, November 13 (ots/PRNewswire) - - Patients Treated With Boosted Invirase 500 Were Significantly Less Likely to Develop Elevated Lipids Than Boosted Lopinavir Promising head to head results presented today indicate that the boosted protease inhibitor (PI/r) Invirase 500/r appears to ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 13.11.2006 - Conergys 50/50/08 growth strategy on course - Overseas sales up almost quadrupled after nine months - Q3 EBIT up 32% over same period last year - Sales target of EUR 800 million ...
Vancouver, Canada, November 7 (ots/PRNewswire) - - TSXv - TK; Frankfurt - TLD; Pinksheets - TKRFF Mr. Andrew Carter, President, is pleased to announce further results of the underground channel samples taken from the 3870 level adit on the Company's 100% owned 2,079 hectare Colquipucro project ...
Amsterdam (ots/PRNewswire) - - Third Quarter Revenue at EUR 390 Million, Down 8% at Constant Exchange Rates, as Market Environment Remains Difficult in Mobile Communication - Year-to-date Pro Forma Revenue at EUR1,237 Million, 1% Lower Than Last Year at Constant Exchange Rates, and Stable at Current Exchange Rates - Deployments of Electronic Passports Projects Lead to 20% Growth in ID & Security in the ...
Luxembourg (ots/PRNewswire) - Third quarter 2006 highlights: - Gemalto combination ongoing: tender offer reopened after the successful first round. - Gemalto integration process well on-track. - Net sales down 11.5% mainly due to strong price pressure in wireless. - Gross margin at 26.7%, with lower margins in all business segments. - Operating loss at 2.7 million euros, including 4.3 ...